Recent Updates
Recently added Catalysts
ABBV Positive Sentiment Score: 70/100

AbbVie to Present at the Leerink Partners Global Healthcare Conference AbbVie (NYSE: ABBV) will participate at the Leerink Partners Global Healthcare Conference on Tuesday, March 11, 2025. Management will participate in...

Key Takeaway: AbbVie (NYSE: ABBV) is set to present at the Leerink Partners Global Healthcare Conference on March 11, 2025, with a fireside chat scheduled for 7:40 a.m. Central time. The event will be accessible through a live audio webcast on AbbVie's Investor Relations website, followed by an archived version later that day. AbbVie aims to showcase its mission of delivering innovative medicines across key therapeutic areas, including immunology and oncology.

Market Sentiment Analysis

POSITIVE FACTORS

  • AbbVie will highlight its innovations in addressing serious health issues.
  • Participation in a prominent healthcare conference shows a proactive approach to investor relations.
  • Management's engagement via a fireside chat suggests transparency and accessibility.

Full Press Release Details

NORTH CHICAGO, Ill. , March 4, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV ) will participate at the Leerink Partners Global Healthcare Conference on Tuesday, March 11, 2025 . Management will participate in a fireside chat at 7:40 a.m. Central time .
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com . An archived edition of the session will be available later that day.
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X (formerly Twitter) , and YouTube.
Media: Investors:
Gabby Tarbert Liz Shea
(224) 244-0111 (847) 935-2211
[email protected] [email protected]

21 %

Frequently Asked Questions

When is AbbVie's participation in the Leerink Partners Conference?

AbbVie will participate on March 11, 2025, at 7:40 a.m. Central time.

Where can I access the live webcast of AbbVie's presentation?

The live audio webcast will be available on AbbVie's Investor Relations website.

What is AbbVie's mission?

AbbVie's mission is to discover and deliver innovative medicines for serious health issues.

Which therapeutic areas does AbbVie focus on?

AbbVie focuses on immunology, oncology, neuroscience, eye care, and aesthetics.

How can I follow AbbVie on social media?

You can follow AbbVie on LinkedIn, Facebook, Instagram, X, and YouTube.

Last updated: Mar 4, 2025